Halozyme Therapeutics
HALO
#2039
Rank
A$12.15 B
Marketcap
$98.70
Share price
2.16%
Change (1 day)
58.19%
Change (1 year)

Halozyme Therapeutics (HALO) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : A$2.68 Billion

According to Halozyme Therapeutics's latest financial reports the company's total liabilities are A$2.68 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Halozyme Therapeutics - Total liabilities on balance sheet (from 2002 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$2.73 B12.87%
2023-12-31A$2.42 B-1.45%
2022-12-31A$2.45 B96.26%
2021-12-31A$1.25 B124.42%
2020-12-31A$0.55 B-17.63%
2019-12-31A$0.67 B149.29%
2018-12-31A$0.27 B-31.94%
2017-12-31A$0.39 B-2.15%
2016-12-31A$0.40 B114.08%
2015-12-31A$0.19 B25.11%
2014-12-31A$0.15 B11.53%
2013-12-31A$0.13 B65.22%
2012-12-31A$82.63 M54.45%
2011-12-31A$53.5 M-23.45%
2010-12-31A$69.89 M-10.62%
2009-12-31A$78.19 M-9.83%
2008-12-31A$86.72 M65.93%
2007-12-31A$52.26 M79.05%
2006-12-31A$29.18 M827.25%
2005-12-31A$3.14 M54.24%
2004-12-31A$2.04 M454.81%
2003-12-31A$0.36 M-66.03%
2002-12-31A$1.08 M16704.16%
2001-12-31A$0 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$0.74 B-72.19%๐Ÿ‡บ๐Ÿ‡ธ USA
A$101.96 B 3,691.54%๐Ÿ‡บ๐Ÿ‡ธ USA
A$29.67 B 1,003.63%๐Ÿ‡บ๐Ÿ‡ธ USA
A$197.61 B 7,248.47%๐Ÿ‡บ๐Ÿ‡ธ USA
A$90.45 B 3,263.76%๐Ÿ‡ซ๐Ÿ‡ท France
A$171.85 B 6,290.34%๐Ÿ‡บ๐Ÿ‡ธ USA